Studion Appoints Brian Harrington as General Manager of Life Sciences Business Unit

BOSTON--(BUSINESS WIRE)--Studion, a technology services company that envisions, designs, and builds engaging digital experiences for Learning and Life Sciences, today announced the promotion of Brian Harrington to General Manager of its Life Sciences business unit. In this expanded role, Harrington will lead the strategy, growth, and delivery of Studion's end-to-end eClinical services, helping life sciences organizations accelerate time to market for life-changing treatments.

Harrington brings deep expertise in the clinical trials landscape and a track record of building high-performing teams and partnerships across the digital health ecosystem. In his prior role in Commercial Development, Harrington leveraged his extensive experience in Customer Success and Operations to strengthen client relationships and shape innovative service offerings that meet the evolving needs of Studion’s clients and the market.

"Brian's understanding of the complexity of clinical trial technology and his ability to think creatively about how to solve it makes him the ideal leader for our Life Sciences business unit," said Furqan Nazeeri, CEO at Studion. "This promotion reflects our continued commitment to being a trusted partner to our clients and a leader in eClinical tech services, including our new managed services offerings for study start-up and study maintenance."

Studion’s Life Sciences business unit is a platform-agnostic eClinical services partner that has designed, built, and tested over 2,000 eCOA, eConsent, and EDC solutions across a range of therapeutic areas. Harrington's appointment comes as demand for compliant, patient-centered eClinical solutions in clinical trials continues to accelerate.

“I’m honored to step into this role at such an exciting time for both Studion and the life sciences industry,” said Harrington. “As the eClinical landscape continues to evolve, our clients are looking for more strategic, scalable ways to deliver with confidence. While staff augmentation remains an important part of our business, I’m especially excited about the continued growth of our study start-up and maintenance managed service offerings. These offerings help eCOA and eClinical companies improve financial and operational predictability, reduce costs, and help bring life-changing therapies to patients faster.”

About Studion
Studion is a technology services firm that creates engaging digital experiences in Learning and the Life Sciences. Studion’s Life Sciences business unit specializes in supporting eClinical technology across the clinical trial lifecycle, including managed services and staff augmentation engagement models. Learn more at gostudion.com.